EU approves low level adventitious presence in GM products no longer on the market
On Tuesday 20 March, the EU Standing Committee for the food Chain and Animal Health voted in favour of a 0.9% threshold for the low level adventitious presence of five GM products that are no longer commercially available. The threshold applies to the five "first-generation" GM crops that are no longer sold by Bayer, Monsanto and Syngenta, as improved products have replaced these. Since the companies no longer market these crops anywhere in the world, they are not seeking renewal for EU market approval. However, the Commission has recognised that "minute traces" of these 5 GM products "might remain present in food or feed products for a certain period of time".
EuropaBio has previously proposed the establishment of adventitious presence thresholds for such GMOs in food and feed products and is very pleased to see that this proposal marks a decisive step in the right direction.
Under European legislation, approvals for these products would have expired next month. Since the companies are not seeking further approvals of these products in the EU, the Standing Committee has proposed to formally "withdraw" the products from the market. According to standard procedure, the European Commission explained these proposals to the European Parliament's Environment Committee ("droit de regard"), a final decision on the proposals is expected to follow within the next five weeks.
Meanwhile, EuropaBio's member companies remain fully committed to developing improved crop varieties using genetic modification. When approved by the EU's regulators for placing on the market these will complement those existing GM crops that have, since 1998, seen an increasing yearly demand from, and been grown by, an increasing number farmers in European Member States.
Most read news
Other news from the department politics & laws

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Martin_R._Dinnes
Witzelsucht
H&E_stain
SIRS-Lab and Analytik Jena cooperate on Sepsis Diagnostics
Enrollment for additional phase I trial of HPV-vaccine - ORYX's vaccine in addition to chemotherapy in HPV-associated cancers
'Corrective genes' closer thanks to enzyme modification - Universite de Montreal - McGill University scientists detail modification of enzyme structure
Cardiac_arrhythmia

Polyethersulfone Microfilter | Microfilters | Sartorius
Elizabeth_Wright_Hubbard
Marshall_M._Parks

Kizoo leads financing round in Reservoir Neuroscience to restore health to the aging brain - A first-in-kind compound reverses disease in blood vessels and repairs the damaged blood-brain barrier
